H.R. 9461

H.R. 9461: To permit the Federal Home Loan Mortgage Corporation and the Federal National Mortgage Association to purchase and securitize certain residential construction loans.

Introduced Scott Fitzgerald (R) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 9461 allows the Federal Home Loan Mortgage Corporation (Freddie Mac) and the Federal National Mortgage Association (Fannie Mae) to buy and bundle certain residential construction loans into securities. This aims to enhance liquidity in the housing market by enabling these government-sponsored enterprises to support the financing of new home construction.

Positive Media Summary

Supporters of H.R. 9461 argue that the bill will stimulate the housing market by providing more funding options for residential construction. They believe it will help address housing shortages and make homeownership more accessible for potential buyers.

Negative Media Summary

Critics of H.R. 9461 express concerns that increasing the role of Freddie Mac and Fannie Mae in construction loans may lead to higher risks for taxpayers. They fear it could encourage irresponsible lending practices and contribute to future housing market instability.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Finance and Financial Sector

The analysis of H.R. 9461, which allows the Federal Home Loan Mortgage Corporation and the Federal National Mortgage Association to purchase and securitize certain residential construction loans, reveals no direct industry overlaps between the bill's subject matter and the sponsor Scott Fitzgerald's top donor industries. The lobbying activity related to this bill primarily involves organizations from the pharmaceutical, telecommunications, and sports sectors, which do not have a direct connection to residential construction financing. The highest lobbying amount noted is $60,000 from Vertex Pharmaceuticals, which is unrelated to the housing finance sector. Given the absence of overlapping interests and the nature of the lobbying activities, the potential for conflicts of interest appears minimal.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
VERTEX PHARMACEUTICALS INCORPORATED MARSHALL & POPP, LLC $60,000
SUN PHARMACEUTICAL INDUSTRIES, INC. MARSHALL & POPP, LLC $60,000
SANOFI U.S. SERVICES, INC. MARSHALL & POPP, LLC $60,000
WAYFINDER GROUP (OBO RESEARCH CORPORATION OF THE UNIVERSITY OF HAWAII) RED MAPLE CONSULTING, LLC $40,000
ECKERD CONNECTS KOUNTOUPES DENHAM CARR & REID, LLC $30,000
SMART APPROACHES TO MARIJUANA OFF HILL STRATEGIES L.L.C. $20,000
FEDERATION OF ELECTRIC POWER COS OF JAPAN GEORGE H. DENISON $10,000
MAYO CLINIC MCDERMOTT WILL & SCHULTE LLP undisclosed
VERIZON COMMUNICATIONS, INC. MARSHALL & POPP, LLC undisclosed
THE BIG TEN CONFERENCE, INC. MARSHALL & POPP, LLC undisclosed
THE BIG 12 CONFERENCE, INC. MARSHALL & POPP, LLC undisclosed
SOUTHEASTERN CONFERENCE MARSHALL & POPP, LLC undisclosed
PAC-12 CONFERENCE MARSHALL & POPP, LLC undisclosed
ATLANTIC COAST CONFERENCE MARSHALL & POPP, LLC undisclosed
SAPPHIRE DIGITAL MARSHALL & POPP, LLC undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Scott Fitzgerald, ranked by total contributions.

Health Professionals $120,000,000
Individuals: $120,000,000 PACs: $0
Retired $37,500,000
Individuals: $37,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us